Loading...

Blinatumomab: Enlisting serial killer T cells in the war against hematologic malignanciess

INTRODUCTION: The approval of blinatumomab signals the long awaited arrival of immunotherapy for acute lymphoblastic leukemia (ALL). Previous options for relapsed or refractory disease were restricted to combination cytotoxic chemotherapy with limited efficacy and significant toxicity. Through an in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Expert Opin Biol Ther
Main Authors: Rogala, Britny, Freyer, Craig W., Ontiveros, Evelena P., Griffiths, Elizabeth A., Wang, Eunice S., Wetzler, Meir
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4994468/
https://ncbi.nlm.nih.gov/pubmed/25985814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.1041912
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!